Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07672756 PJ-008 Phenylketonurias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672756 clinical trial report covering PJ-008, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07673068 Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life) Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673068 clinical trial report covering Recombinant Hepatitis B Therapeutic Vaccine(Grand Theravac Life), Phase 1, endpoints, sponsor, geography, readou
Latest Hotspot
8 min read
NCT07673601 ARGX-119 Herpesviridae Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673601 clinical trial report covering ARGX-119, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07673900 Semaglutide (Terrestrial) Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07673900 clinical trial report covering Semaglutide (Terrestrial), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07674615 Sacituzumab govitecan-hziy Primary peritoneal carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674615 clinical trial report covering Sacituzumab govitecan-hziy, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07674693 Retreatment Rhenium Liposome Metastatic Malignant Neoplasm to the Leptomeninges Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674693 clinical trial report covering Retreatment Rhenium Liposome, Phase 1, endpoints, sponsor, geography, readout timing and development white space
Latest Hotspot
8 min read
NCT07672717 Cabotegravir sodium HIV Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672717 clinical trial report covering Cabotegravir sodium, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07674966 Atropine Sulfate Myopia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07674966 clinical trial report covering Atropine Sulfate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07672483 IL-12 (SYTE) Refractory Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672483 clinical trial report covering IL-12 (SYTE), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07676357 RFUS-949 Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676357 clinical trial report covering RFUS-949, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07675590 TIX-100 Overweight Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07675590 clinical trial report covering TIX-100, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07676266 C-CAR168 Neuromyelitis Optica Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676266 clinical trial report covering C-CAR168, Phase 1, endpoints, sponsor, geography, readout timing and development white space.